<DOC>
	<DOC>NCT01072565</DOC>
	<brief_summary>The purpose of this study is to evaluate the effectiveness of Self Monitoring of Blood Glucose (SMBG) for clinical decisions related to the management of type 2 diabetes and to determine the benefit of using Continuous Glucose Monitoring (CGM) for clinical diabetes management.</brief_summary>
	<brief_title>Modal Day Analysis of Self Monitoring Blood Glucose Versus Continuous Glucose Monitoring</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<criteria>Male or female subjects ≥18 and ≤75 years of age Clinical diagnosis of diabetes Diabetes duration ≥ 1 year HbA1c ≥7.2% Diabetes can be treated with any therapy including medical nutrition therapy alone and any pharmaceutical therapy Taken prednisone or cortisone medications in the previous 30 days Currently pregnant or planning pregnancy during the study period Presence of any severe medical or psychological condition or chronic conditions/infections that in the opinion of the Investigator would compromise the subject's safety or successful participation in the study Unable to follow the study protocol Unable to speak, read and write in English</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Type 2 Diabetes</keyword>
	<keyword>A1c</keyword>
	<keyword>Continuous Glucose Monitoring</keyword>
	<keyword>Blood Glucose</keyword>
</DOC>